WO2012093919A3 - 백혈병 치료용 조성물 및 몰약 추출물의 제조방법 - Google Patents

백혈병 치료용 조성물 및 몰약 추출물의 제조방법 Download PDF

Info

Publication number
WO2012093919A3
WO2012093919A3 PCT/KR2012/000216 KR2012000216W WO2012093919A3 WO 2012093919 A3 WO2012093919 A3 WO 2012093919A3 KR 2012000216 W KR2012000216 W KR 2012000216W WO 2012093919 A3 WO2012093919 A3 WO 2012093919A3
Authority
WO
WIPO (PCT)
Prior art keywords
myrrh
preparing
composition
myrrh extract
treating leukemia
Prior art date
Application number
PCT/KR2012/000216
Other languages
English (en)
French (fr)
Other versions
WO2012093919A2 (ko
Inventor
황성연
정경채
Original Assignee
주식회사 한국전통의학연구소
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 한국전통의학연구소 filed Critical 주식회사 한국전통의학연구소
Publication of WO2012093919A2 publication Critical patent/WO2012093919A2/ko
Publication of WO2012093919A3 publication Critical patent/WO2012093919A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

본 발명은 건조된 몰약(沒藥, myrrh) 분쇄물로부터 지방족 극성 용매를 이용하여 추출되고 유효성분인 몰약 추출물 및 약리학적으로 허용 가능한 담체들을 포함하는 백혈병 치료용 조성물을 제공한다. 상기 몰약 추출물은 미량만으로도 백혈병 세포의 사멸 및 증식 억제를 유도할 수 있어 다양한 약학적 제형에 폭 넓게 적용될 수 있다.
PCT/KR2012/000216 2011-01-08 2012-01-09 백혈병 치료용 조성물 및 몰약 추출물의 제조방법 WO2012093919A2 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020110002022A KR101782962B1 (ko) 2011-01-08 2011-01-08 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
KR10-2011-0002022 2011-01-08

Publications (2)

Publication Number Publication Date
WO2012093919A2 WO2012093919A2 (ko) 2012-07-12
WO2012093919A3 true WO2012093919A3 (ko) 2012-12-06

Family

ID=46457898

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2012/000216 WO2012093919A2 (ko) 2011-01-08 2012-01-09 백혈병 치료용 조성물 및 몰약 추출물의 제조방법

Country Status (2)

Country Link
KR (1) KR101782962B1 (ko)
WO (1) WO2012093919A2 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101454161B1 (ko) * 2013-10-30 2014-10-29 주식회사 해피콜 몰약수지 용액과 수용액 및 그 제조방법 그리고 그 몰약 수용액을 포함하는 제품
CN104587443A (zh) * 2015-02-25 2015-05-06 彭平 一种用于原发性抗磷脂综合症的中药制剂及制备方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920005991A (ko) * 1990-09-24 1992-04-27 김병선 백혈병 치료약의 제법
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
KR20010026175A (ko) * 1999-09-03 2001-04-06 서경배 천연식물 추출물을 함유하는 미백용 조성물
CN101129606A (zh) * 2007-08-02 2008-02-27 徐平 一种治疗白血病的中药
CN101596237A (zh) * 2009-05-11 2009-12-09 刘昭前 一种治疗慢性粒细胞白血病的中药制剂

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR920005991A (ko) * 1990-09-24 1992-04-27 김병선 백혈병 치료약의 제법
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
KR20010026175A (ko) * 1999-09-03 2001-04-06 서경배 천연식물 추출물을 함유하는 미백용 조성물
CN101129606A (zh) * 2007-08-02 2008-02-27 徐平 一种治疗白血病的中药
CN101596237A (zh) * 2009-05-11 2009-12-09 刘昭前 一种治疗慢性粒细胞白血病的中药制剂

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WEN-LIH CHANG ET AL.: "Experimental Effects of Sunjeonhwadok-Tang on the Proliferation of Cancer Cells and Immunocytes - Focusing around Combined Effects of Anticarcinogen", THE JOURNAL OF KOREAN ORIENTAL MEDICAL OPHTHALMOLOGY & OTOLARYNGOLOGY & DERMATOLOGY, vol. 18, no. 1, April 2005 (2005-04-01), pages 104 - 115, XP053018690 *

Also Published As

Publication number Publication date
WO2012093919A2 (ko) 2012-07-12
KR20120080676A (ko) 2012-07-18
KR101782962B1 (ko) 2017-10-23

Similar Documents

Publication Publication Date Title
WO2014179446A3 (en) Microrna compounds and methods for modulating mir-122
WO2012106303A1 (en) Pharmaceutical formulations including an amine compound
WO2014153235A3 (en) Arginine methyltransferase inhibitors and uses thereof
WO2014153100A3 (en) Arginine methyltransferase inhibitors and uses thereof
MY185491A (en) Macrocylic pyrimidine derivatives
MX369799B (es) Derivados de piridina macrociclicos.
WO2013100566A8 (en) Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
MX2016012668A (es) Derivados de 4,5,6,7-tetrahidro-pirazolo[1,5-a]pirazina sustituidos y derivados de 5,6,7,8-tetrahidro-4h-pirazolo[1,5-a][1 ,4]diazepina como inhibidores de ros1.
WO2012148247A3 (ko) 올레아놀린산 아세테이트를 유효성분으로 포함하는 tlr 및 il-6 매개성 질환예방 또는 치료용 약학적 조성물
EP4360621A3 (en) Formulations of bendamustine
EA201491013A1 (ru) Пиразиновые ингибиторы киназы
EP2995304A4 (en) Composition for preventing or treating symptoms of menopause comprising soybean extract comprising coumestrol as an active ingredient
PH12016501461A1 (en) 5-biphenyl-4-heteroarylcarbonylamino-pentanoic acid derivatives as neprilysin inhibitors
WO2013109388A3 (en) 1,5-naphthyridine derivatives and melk inhibitors containing the same
MY168212A (en) A new therapeutical composition containing apomorphine as active ingredient
NZ721780A (en) Heterocyclic modulators of lipid synthesis for use against cancer and viral infections
EP2799082A4 (en) PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORAL DISEASES OR ASTHMA CONTAINING A STOREM STEREMIA OVALIFOLIA EXTRACT OR A FRACTION OF IT AS AN ACTIVE SUBSTANCE
MX2017008074A (es) DERIVADOS DE IMIDAZOPIRIDAZINA COMO INHIBIDORES DE FOSFOINOSITIDA-3-QUINASAS BETA (PI3Kß).
WO2012093919A3 (ko) 백혈병 치료용 조성물 및 몰약 추출물의 제조방법
EA201691741A1 (ru) Фармацевтическая композиция
EP3552606A4 (en) COMPOSITION FOR THE PREVENTION OR TREATMENT OF DISEASES RESULTING FROM CAFFEINE ABUSE WITH EUODIA EXTRACT OR EVODIAMINE AS THE ACTIVE SUBSTANCE
SG194711A1 (en) Processes for preparing inhibitors of the hepatitis c virus
EP2815742A4 (en) IMPROVED ADMINISTRATIVE FORM WITH EXTRACT FROM THE RINDER OF LIRIODENDRON TULIPIFERA AS AN ACTIVE SUBSTANCE
WO2012175996A3 (en) Drug delivery formulations
MX2014010926A (es) Composicion herbaria para el tratamiento de transtornos metabolicos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12732050

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12732050

Country of ref document: EP

Kind code of ref document: A2